Approval Year
| Substance Class |
Mixture
Created
by
admin
on
Edited
Sat Dec 16 10:27:55 GMT 2023
by
admin
on
Sat Dec 16 10:27:55 GMT 2023
|
| Record UNII |
QVU94XE61A
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
List_of_fentanyl_analogues click to edit
Created by
admin on Sat Dec 16 10:27:55 GMT 2023 , Edited by admin on Sat Dec 16 10:27:55 GMT 2023
|
||
|
WIKIPEDIA |
Designer-drugs-3-Methylfentanyl
Created by
admin on Sat Dec 16 10:27:55 GMT 2023 , Edited by admin on Sat Dec 16 10:27:55 GMT 2023
|
||
|
DEA NO. |
9813
Created by
admin on Sat Dec 16 10:27:55 GMT 2023 , Edited by admin on Sat Dec 16 10:27:55 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
172946
Created by
admin on Sat Dec 16 10:27:55 GMT 2023 , Edited by admin on Sat Dec 16 10:27:55 GMT 2023
|
PRIMARY | |||
|
61996
Created by
admin on Sat Dec 16 10:27:55 GMT 2023 , Edited by admin on Sat Dec 16 10:27:55 GMT 2023
|
PRIMARY | |||
|
DTXSID30962228
Created by
admin on Sat Dec 16 10:27:55 GMT 2023 , Edited by admin on Sat Dec 16 10:27:55 GMT 2023
|
PRIMARY | |||
|
42045-86-3
Created by
admin on Sat Dec 16 10:27:55 GMT 2023 , Edited by admin on Sat Dec 16 10:27:55 GMT 2023
|
PRIMARY | |||
|
61092
Created by
admin on Sat Dec 16 10:27:55 GMT 2023 , Edited by admin on Sat Dec 16 10:27:55 GMT 2023
|
PRIMARY | |||
|
3-METHYLFENTANYL
Created by
admin on Sat Dec 16 10:27:55 GMT 2023 , Edited by admin on Sat Dec 16 10:27:55 GMT 2023
|
PRIMARY | |||
|
QVU94XE61A
Created by
admin on Sat Dec 16 10:27:55 GMT 2023 , Edited by admin on Sat Dec 16 10:27:55 GMT 2023
|
PRIMARY | |||
|
DB01571
Created by
admin on Sat Dec 16 10:27:55 GMT 2023 , Edited by admin on Sat Dec 16 10:27:55 GMT 2023
|
PRIMARY |
All of the following components must be present:
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
||
|
|
TARGET -> AGONIST |
|
||
|
|
TARGET -> AGONIST |
|
||
|
DERIVATIVE -> PARENT |
|
||
|
TARGET -> AGONIST |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
Assumed inactivity from despropionyl fentanyl
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
IMPURITY -> PARENT |
Immediate precursor to 3-METHYLFENTANYL.
|
||
|
|
PARENT -> IMPURITY |
Immediate precursor.
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |